MEN4 is the most recent member of the MEN syndromes group; it was first described in 2006 as an autosomal dominant disorder due to a mutation in the cyclin-dependent kinase inhibitor 1B (CDNK1B) gene [15]. The gene discussed is CDKN1B; the disease is multiple endocrine neoplasia.